Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Gynecologic Oncology
|
January 30, 2017
Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy
C K Ho, E N Kornaga, A C Klimowicz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2015
Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study
B J Monk, P Ghatage, T Parekh, et al.
Gynecologic Oncology
|
August 14, 2018
Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: System-wide implementation and audit leads to improved value and patient outcomes
S P Bisch, T Wells, L Gramlich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2018
Safety and dose modification for patients receiving niraparib
J S Berek, U A Matulonis, U Peen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 17, 2018
Safety and dose modification for patients receiving niraparib
J S Berek, U A Matulonis, U Peen, et al.
Journal of the National Cancer Institute
|
October 13, 2010
Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel
P Hoskins, I Vergote, A Cervantes, et al.
Current Oncology (Toronto, Ont.)
|
October 5, 2011
Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective
A M Oza, V Castonguay, D Tsoref, et al.
British Journal of Cancer
|
October 29, 2014
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study
M Köbel, J Madore, S J Ramus, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|
April 28, 2022
2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021
G Johnson, A Vergis, B Unger, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Gynecologic Oncology
|
January 30, 2017
Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy
C K Ho, E N Kornaga, A C Klimowicz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2015
Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study
B J Monk, P Ghatage, T Parekh, et al.
Gynecologic Oncology
|
August 14, 2018
Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: System-wide implementation and audit leads to improved value and patient outcomes
S P Bisch, T Wells, L Gramlich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2018
Safety and dose modification for patients receiving niraparib
J S Berek, U A Matulonis, U Peen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 17, 2018
Safety and dose modification for patients receiving niraparib
J S Berek, U A Matulonis, U Peen, et al.
Journal of the National Cancer Institute
|
October 13, 2010
Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel
P Hoskins, I Vergote, A Cervantes, et al.
Current Oncology (Toronto, Ont.)
|
October 5, 2011
Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective
A M Oza, V Castonguay, D Tsoref, et al.
British Journal of Cancer
|
October 29, 2014
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study
M Köbel, J Madore, S J Ramus, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|
April 28, 2022
2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021
G Johnson, A Vergis, B Unger, et al.
Page
of 2